Answer
Its licence covers adults with primary advanced or recurrent endometrial cancer. The treatment context depends on previous therapy and tumour characteristics.
Sources for this answer
- JEMPERLI 500 mg concentrate for solution for infusion — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.